VF
FNCH

Virtu Financial’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Virtu Financial’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-506
Closed -$25K – 2406
2022
Q3 		$25K Buy
+506
New +$35.2K ﹤0.01% 1352

Other funds holding FNCH

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
TA
TRB Advisors New York $146M AUM 3.71% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Virtu Financial's FNCH Position: Q4 2022 in Review

Virtu Financial sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q4 2022, closing a stake of 506 shares — an estimated $25K sold.

Virtu Financial first reported a position in FNCH in Q3 2022 and held it in 1 quarter. The position peaked at $25K in Q3 2022. 40 funds tracked by Wall St. Rank hold FNCH as of Q4 2022.

  • Virtu Financial reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 506 Finch Therapeutics Group, Inc. Common Stock shares in Q4 2022, an estimated $25K.
  • Virtu Financial first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Virtu Financial's Finch Therapeutics Group, Inc. Common Stock position peaked at $25K in Q3 2022.
  • 40 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.